Range
12.15 - 13.19
Vol / Avg.
175.2K/135.4K
Div / Yield
-
52 Wk
11.5 - 28.21
Mkt Cap
286M
Payout Ratio
-
Open
12.15
P/E
-
EPS
-1.63
Shares
21.7M
Outstanding
21.7M
Total Float
18.9M
Benzinga - May 7, 2021, 3:21PM
Benzinga - May 6, 2021, 7:05AM
Benzinga - Apr 15, 2021, 12:03PM
Benzinga - Apr 15, 2021, 10:08AM
Benzinga - Apr 15, 2021, 6:41AM
Benzinga - Mar 31, 2021, 8:52AM
Benzinga - Mar 24, 2021, 12:26PM
Benzinga - Mar 24, 2021, 8:20AM
Benzinga - Mar 24, 2021, 7:16AM
Benzinga - Feb 26, 2021, 6:35AM
Benzinga - Feb 18, 2021, 8:26AM
Benzinga - Feb 18, 2021, 6:36AM
Benzinga - Feb 17, 2021, 10:52AM
Benzinga - Feb 17, 2021, 8:49AM
Benzinga - Feb 17, 2021, 6:34AM
Benzinga - Nov 6, 2020, 8:19AM
Benzinga - Nov 5, 2020, 4:02PM
load more
Sector: Health Care.Industry: Biotechnology
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which includes IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of ROR?t; and IMU-856 targets the restoration of the intestinal barrier function.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-02
REV
Q1 2021Est.ActualSurprise
EPS-0.710-1.630 -0.9200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IMUXImmunic0%286M

Immunic Frequently Asked Questions

Q

How do I buy Immunic (IMUX) stock?

A

You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immunic's (IMUX) competitors?

A

Other companies in Immunic’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), HOOKIPA Pharma (NASDAQ:HOOK), Innate Pharma (NASDAQ:IPHA), Kezar Life Sciences (NASDAQ:KZR) and Infinity Pharmaceuticals (NASDAQ:INFI).

Q

What is the target price for Immunic (IMUX) stock?

A

The latest price target for Immunic (NASDAQ: IMUX) was reported by Aegis Capital on April 15, 2021. The analyst firm set a price target for 55.00 expecting IMUX to rise to within 12 months (a possible 318.25% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immunic (IMUX)?

A

The stock price for Immunic (NASDAQ: IMUX) is $13.15 last updated Today at 8:00:02 PM.

Q

Does Immunic (IMUX) pay a dividend?

A

There are no upcoming dividends for Immunic.

Q

When is Immunic (NASDAQ:IMUX) reporting earnings?

A
Immunic’s Q2 earnings are confirmed for after-market on August 2, 2021.
Q

Is Immunic (IMUX) going to split?

A

There is no upcoming split for Immunic.

Q

What sector and industry does Immunic (IMUX) operate in?

A

Immunic is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.